The serum FOLR1 level discriminated between HCC and CHC patients with an area under the receiver operating characteristic curve (AUROC) of 0.685 (Fig. 3C), which was comparable to the AFP level, with an AUROC of 0.708 (Fig. 3D). The gene discussed is FOLR1; the disease is hepatocellular carcinoma.